123 related articles for article (PubMed ID: 38374690)
1. A 120-Minute Saline Infusion Test for the Confirmation of Primary Aldosteronism: A Pilot Study.
Golani T; Bleier J; Kaplan A; Hod T; Sharabi Y; Leibowitz A; Grossman E; Shlomai G
Am J Hypertens; 2024 May; 37(6):415-420. PubMed ID: 38374690
[TBL] [Abstract][Full Text] [Related]
2. Plasma Aldosterone After Seated Saline Infusion Test Outperforms Captopril Test at Predicting Clinical Outcomes After Adrenalectomy for Primary Aldosteronism.
Wu CH; Wu V; Yang YW; Lin YH; Yang SY; Lin PC; Chang CC; Tsai YC; Wang SM;
Am J Hypertens; 2019 Oct; 32(11):1066-1074. PubMed ID: 31216359
[TBL] [Abstract][Full Text] [Related]
3. Using plasma aldosterone concentrations at 1 h of saline infusion test for the diagnosis of primary aldosteronism.
Phonanuwong R; Jannoo S; Chanthanuwat S; Soonthornpun S
J Hypertens; 2023 Sep; 41(9):1493-1497. PubMed ID: 37432888
[TBL] [Abstract][Full Text] [Related]
4. Sodium Infusion Test for Diagnosis of Primary Aldosteronism in Chinese Population.
Li Y; Liu Y; Li J; Wang X; Yu Y
J Clin Endocrinol Metab; 2016 Jan; 101(1):89-95. PubMed ID: 26565948
[TBL] [Abstract][Full Text] [Related]
5. Confirmatory testing of primary aldosteronism with saline infusion test and LC-MS/MS.
Fuss CT; Brohm K; Kurlbaum M; Hannemann A; Kendl S; Fassnacht M; Deutschbein T; Hahner S; Kroiss M
Eur J Endocrinol; 2021 Jan; 184(1):167-178. PubMed ID: 33112272
[TBL] [Abstract][Full Text] [Related]
6. Suppression of Aldosterone Secretion After Recumbent Saline Infusion Does Not Exclude Lateralized Primary Aldosteronism.
Cornu E; Steichen O; Nogueira-Silva L; Küpers E; Pagny JY; Grataloup C; Baron S; Zinzindohoue F; Plouin PF; Amar L
Hypertension; 2016 Oct; 68(4):989-94. PubMed ID: 27600182
[TBL] [Abstract][Full Text] [Related]
7. A combination of captopril challenge test after saline infusion test improves diagnostic accuracy for primary aldosteronism.
Lin C; Yang J; Fuller PJ; Jing H; Song Y; He W; Du Z; Luo T; Cheng Q; Yang S; Wang H; Li Q; Hu J;
Clin Endocrinol (Oxf); 2020 Feb; 92(2):131-137. PubMed ID: 31774187
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Saline Infusion Test and the Captopril Challenge Test in Chinese Patients With Primary Aldosteronism.
Meng X; Li Y; Wang X; Li J; Liu Y; Yu Y
J Clin Endocrinol Metab; 2018 Mar; 103(3):853-860. PubMed ID: 29300995
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore.
Loh KC; Koay ES; Khaw MC; Emmanuel SC; Young WF
J Clin Endocrinol Metab; 2000 Aug; 85(8):2854-9. PubMed ID: 10946893
[TBL] [Abstract][Full Text] [Related]
10. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
11. Case detection in primary aldosteronism: high-diagnostic value of the aldosterone-to-renin ratio when performed under standardized conditions.
Vorselaars WMCM; Valk GD; Vriens MR; Westerink J; Spiering W
J Hypertens; 2018 Jul; 36(7):1585-1591. PubMed ID: 29528872
[TBL] [Abstract][Full Text] [Related]
12. Criteria for diagnosing primary aldosteronism on the basis of liquid chromatography-tandem mass spectrometry determinations of plasma aldosterone concentration.
Baron S; Amar L; Faucon AL; Blanchard A; Baffalie L; Faucard C; Travers S; Pagny JY; Azizi M; Houillier P
J Hypertens; 2018 Jul; 36(7):1592-1601. PubMed ID: 29677048
[TBL] [Abstract][Full Text] [Related]
13. Aldosterone Reduction Rate After Saline Infusion Test May Be a Novel Prediction in Patients With Primary Aldosteronism.
Nagano H; Kono T; Saiga A; Kubota Y; Fujimoto M; Felizola SJA; Ishiwata K; Tamura A; Higuchi S; Sakuma I; Hashimoto N; Suzuki S; Koide H; Takeshita N; Sakamoto S; Ban T; Yokote K; Nakamura Y; Ichikawa T; Uno T; Tanaka T
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31628466
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma.
Rossi GP; Belfiore A; Bernini G; Desideri G; Fabris B; Ferri C; Giacchetti G; Letizia C; Maccario M; Mallamaci F; Mannelli M; Montemurro D; Palumbo G; Rizzoni D; Rossi E; Semplicini A; Agabiti-Rosei E; Pessina AC; Mantero F;
J Hypertens; 2007 Jul; 25(7):1433-42. PubMed ID: 17563566
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of Primary Aldosteronism by Seated Saline Suppression Test-Variability Between Immunoassay and HPLC-MS/MS.
Thuzar M; Young K; Ahmed AH; Ward G; Wolley M; Guo Z; Gordon RD; McWhinney BC; Ungerer JP; Stowasser M
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31676899
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of Screening and Confirmatory Tests of Primary Aldosteronism in Diagnosing Aldosterone Producing Adenoma].
Hu FQ; Huang J; Huang H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 May; 49(3):469-473. PubMed ID: 30014653
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the shortened and standard saline infusion tests for primary aldosteronism diagnostics.
Yamashita K; Yatabe M; Seki Y; Bokuda K; Watanabe D; Shimizu S; Morimoto S; Ichihara A
Hypertens Res; 2020 Oct; 43(10):1113-1121. PubMed ID: 32385484
[TBL] [Abstract][Full Text] [Related]
18. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol.
Giacchetti G; Ronconi V; Lucarelli G; Boscaro M; Mantero F
J Hypertens; 2006 Apr; 24(4):737-45. PubMed ID: 16531803
[TBL] [Abstract][Full Text] [Related]
19. [The value of midnight 1 mg dexamethasone suppression test combined with ACTH stimulation test in the diagnosis of primary aldosteronism subtypes].
Qiu P; Zhang L; Jiang DY; Zang L; Guo QH; Lyu ZH; Mu YM
Zhonghua Yi Xue Za Zhi; 2024 Jun; 104(24):2242-2248. PubMed ID: 38901981
[No Abstract] [Full Text] [Related]
20. Plasma aldosterone level within the normal range is less associated with cardiovascular and cerebrovascular risk in primary aldosteronism.
Murata M; Kitamura T; Tamada D; Mukai K; Kurebayashi S; Yamamoto T; Hashimoto K; Hayashi RD; Kouhara H; Takeiri S; Kajimoto Y; Nakao M; Hamasaki T; Otsuki M; Shimomura I
J Hypertens; 2017 May; 35(5):1079-1085. PubMed ID: 28129245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
